Cabka N.V. (CABKA)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 2.000 |
|---|---|
| 52-week range | 1.405 – 2.180 |
| Return, 1 month / 3 months | −1.0% / +0.0% |
| Return, 1 year / 3 years | +6.7% / −73.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 43.6% |
| Worst drawdown (1 year) | -29.0% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cabka is a Dutch company that turns recycled plastic into products for industry and logistics. It makes plastic pallets, large containers and crates used for transporting and storing goods, serving customers in logistics, retail and agriculture. The business is built around collecting and reprocessing plastic waste and moulding it into durable items, with operations in the Netherlands and other European countries. Its customers are mainly businesses that need reusable transport and storage equipment rather than consumers.
On this site Cabka N.V. appears as a stock on the Euronext Amsterdam (Netherlands), code CABKA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cabka N.V. (CABKA) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 2.000 on 22 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 69 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.7% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.6% | ||
| From 52-week high | -5.7% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 1.0% | ||
| 12-month return, skipping the last month | 7.7% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.0% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 5.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −4.8% |
|---|---|
| 1 month | −1.0% |
| 3 months | +0.0% |
| 6 months | +1.0% |
| 1 year | +6.7% |
| 3 years | −73.0% |
| 5 years | −78.8% |
Signals
| 50-day / 200-day average | 2.020 / 1.894 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.077 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Aug 2024 | EUR 0.1500 |
| 17 Aug 2023 | EUR 0.0507 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.